AZD3839: Clinical Trials

1 trial of AZD3839, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow AZD3839: new trials by email Literature Review of AZD3839 trials Research Report on AZD3839

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers
AZD3839, AZD3839 Placebo - Alzheimer's Disease, Safety
Phase 1CompletedAstraZeneca722011-06-012012-04-06

Conditions studied

Alzheimer Disease (1)

Sponsors

AstraZeneca (1)

Countries

United Kingdom (1)

Top investigators

Dr Darren Wilbraham, MBBS DCPSA (1)  ·  Dr Paul Bjornsson (1)